FrancophonIA/ELRC3.0 huggingface dataset:
English: The Physician information about Truxima should contain the following key elements:
Croatian: Informacije za liječnike o lijeku Truxima moraju sadržavati sljedeće ključne elemente:
English: • severe blistering skin conditions that can be life-threatening.
Croatian: stvaranje teških plikova po koži koji mogu ugroziti život.
English: • The need to check, prior to Truxima treatment, for infections, for immunosuppression, for prior/current medication affecting the immune system and recent history of, or planned, vaccination
Croatian: imunosupresiju, prethodnu/trenutačnu primjenu lijekova koji djeluju na imunološki sustav te nedavna ili planirana cijepljenja.
English: In patients with rheumatoid arthritis, granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis in disease remission or pemphigus vulgaris, premedication with 100 mg intravenous methylprednisolone should be completed 30 minutes prior to Truxima infusions to decrease the incidence and severity of infusion related reactions (IRRs).
Croatian: U bolesnika s reumatoidnim artritisom, granulomoatozom s poliangitisom (Wegenerovom granulomatozom), mikroshkopskim poliangitisom ili običnim pemfigusom kod kojih je bolest u remisiji treba primijeniti premedikaciju metilprednizolonom u dozi od 100 mg intravenski radi smanjenja incidencije i težine reakcija povezanih s infuzijom, a primjena mora završiti 30 minuta prije početka infuzije lijeka Truxima.
English: The chemotherapy should be given after the Truxima infusion.
Croatian: Kemoterapiju treba dati nakon infuzije lijeka Truxima.
English: In patients with granulomatosis with polyangiitis or microscopic polyangiitis, the number of peripheral blood B cells decreased to <10 cells/μL after two weekly infusions of rituximab 375 mg/m2, and remained at that level in most patients up to the 6 month time point.
Croatian: U bolesnika s granulomatozom s poliangiitisom i mikroskopskim poliangiitisom broj perifernih B stanica smanjio se na < 10 stanica/µl nakon dvije tjedne infuzije rituksimaba u dozi od 375 mg/m2 i održao na toj razini u većine bolesnika do trenutka mjere ishoda nakon 6 mjeseci.
English: Truxima monotherapy is indicated for treatment of patients with stage III-IV follicular lymphoma who are chemo-resistant or are in their second or subsequent relapse after chemotherapy.
Croatian: Monoterapija lijekom Truxima indicirana je u liječenju bolesnika oboljelih od folikularnog limfoma stadija III-IV koji su rezistentni na kemoterapiju ili su u drugom odnosno sljedećem relapsu nakon kemoterapije.
English: albumin, B symptoms, bulky disease, extranodal sites, bone marrow involvement), the risk ratios for event-free survival and overall survival (R-CHOP compared with CHOP) were less than 0.83 and 0.95 respectively.
Croatian: Eastern Cooperative Oncology Group), koncentraciju β2-mikroglobulina, koncentraciju LDH-a, koncentraciju albumina, B simptome, proširenost tumora, ekstranodalna sijela, zahvaćenost koštane srži) omjer rizika za preživljenje bez događaja (R-CHOP u odnosu na CHOP) bio je manji od 0,83, a za ukupno preživljenje manji od 0,95.
English: • a feeling of fullness or a throbbing pain behind the nose, cheeks and eyes (sinusitis), pain in the abdomen, vomiting and diarrhoea, breathing problems
Croatian: osjećaj začepljenosti ili pulsirajuća bol iza nosa, obraza i očiju (sinusitis), bol u trbuhu, povraćanje i proljev, tegobe s disanjem gljivična infekcija stopala (atletsko stopalo)
English: A course of Truxima consists of two 1000 mg intravenous infusions.
Croatian: Ciklus liječenja lijekom Truxima čine dvije intravenske infuzije od 1000 mg.
English: Although subgroups were small, rituximab maintenance treatment provided a significant benefit in terms of overall survival for both patients responding to CHOP and patients responding to R-CHOP, although longer follow-up is required to confirm this observation.
Croatian: Iako su podskupine bile male, terapija održavanja rituksimabom donijela je značajnu korist u smislu ukupnog preživljenja kako bolesnicima koji su odgovorili na CHOP
English: • If you are having Truxima alone Truxima will be given to you once a week for 4 weeks.
Croatian: Lijek Truxima primat ćete jedanput na tjedan tijekom 4 tjedna.
English: What Truxima is used for
Croatian: Što je Truxima i za što se koristi
English: 1 mg/kg/day (not to exceed 80 mg/day, and tapered as rapidly as possible based on clinical need) during and after the 4 week induction course of Truxima treatment.
Croatian: 1 mg/kg na dan (ne više od 80 mg na dan i što brže postupno smanjivati dozu, ovisno o kliničkoj potrebi).
English: Ear and labyrinth tinnitus, ear pain hearing loss5
Croatian: Poremećaji uha i labirinta tinitus, bol u ušima gubitak sluha5
English: • What you need to know before having
Croatian: Što morate znati prije nego počnete primati lijek Truxima
English: Injury, Poisoning and Procedural Complications
Croatian: Ozljede, trovanja i proceduralne komplikacije reakcije povezane s infuzijom2
English: Truxima is provided in sterile, preservative-free, non-pyrogenic, single use vials.
Croatian: Truxima je dostupna u sterilnim, jednokratnim apirogenim bočicama, bez konzervansa.
English: Immunisations The safety of immunisation with live viral vaccines, following rituximab therapy has not been studied for NHL and CLL patients and vaccination with live virus vaccines is not recommended.
Croatian: Imunizacija Sigurnost imunizacije živim virusnim cjepivima nakon liječenja lijekom rituksimaba nije ispitivana u bolesnika s NHL-om i KLL-om pa se cijepljenje živim virusnim cjepivima ne preporučuje.
English: Truxima are possible.
Croatian: Truxima mogu se ponavljati.
English: This medicinal product contains 52.6 mg sodium per 10 mL vial, equivalent to 2.6% of the WHO recommended maximum daily intake of 2 g sodium for an adult.
Croatian: Pomoćne tvari s poznatim učinkom: Ovaj lijek sadrži 52,6 mg natrija po bočici od 10 mL, što odgovara 2,6% maksimalnog dnevnog unosa od 2g natrija prema preporukama SZO za odraslu osobu.
English: The majority of patients (81%) showed signs of B
Croatian: Većina je bolesnika (81 %) pokazala znakove povrata B stanica, uz vrijednosti od > 10 stanica/µl do 12.
English: • allergic reactions that are most likely to occur during an infusion, but can occur up to 24-hours after infusion
Croatian: alergijske reakcije koje su najvjerojatnije tijekom infuzije, ali se mogu javiti do 24 sata nakon infuzije dugotrajna depresija opadanje kose
English: Your doctor may decide to treat you longer with Truxima (up to 5 years), depending on how you respond to the medicine.
Croatian: Ovisno o tome kako odgovorite na lijek, liječnik će Vam možda produljiti liječenje lijekom Truxima (do 5 godina).
English: Truxima works best in those who have a positive blood test to rheumatoid factor (RF) and/or anti-cyclic citrullinated peptide (anti-CCP).
Croatian: Najbolje odgovor na lijek Truxima uočen je u bolesnika koji imaju pozitivan nalaz testa za reumatoidni faktor (RF) i/ili protutijela na cikličke citrulinirane peptide (anti-CCP) u krvi.
English: EULAR Response (Good/Moderate)
Croatian: EULAR odgovor (dobar/umjeren) Srednja vrijednost promjene rezultata aktivnosti bolesti (DAS)
English: INFORMATION IN BRAILLE truxima 500 mg
Croatian: truxima 500 mg
English: Truxima is indicated for the treatment of patients with moderate to severe pemphigus vulgaris (PV).
Croatian: Truxima je indicirana za liječenje bolesnika s umjerenim do teškim oblikom običnog pemfigusa (PV).
English: If you have rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis or pemphigus vulgaris also tell your doctor
Croatian: Imate li reumatoidni artritis, granulomatozu s poliangiitisom, mikroskopski poliangiitis ili obični pemfigus, obavijestite svog liječnika
English: Truxima is used for the treatment of granulomatosis with polyangiitis (formerly called Wegener's granulomatosis) or microscopic polyangiitis, taken in combination with corticosteroids.
Croatian: Truxima se u kombinaciji s kortikosteroidima primjenjuje za poticanje remisije granulomatoze s poliangiitisom (ranije se zvala Wegenerova granulomatoza) i mikroskopskog poliangiitisa.
English: INFORMATION IN BRAILLE truxima 100 mg
Croatian: truxima 100 mg
English: Premedication consisting of an anti-pyretic and an antihistaminic, e.g. paracetamol and diphenhydramine, should always be given before each administration of Truxima.
Croatian: Prije svake primjene lijeka Truxima uvijek treba primijeniti premedikaciju koja obuhvaća antipiretik i antihistaminik, npr. paracetamol i difenhidramin.
English: d) Granulomatosis with polyangiitis or microscopic polyangiitis
Croatian: d) granulomatoze s poliangiitisom ili mikroskopskog poliangiitisa
English: The recommended dosage of Truxima in combination with chemotherapy for previously untreated and relapsed/refractory patients is 375 mg/m2 body surface area administered on day 0 of the first treatment cycle followed by 500 mg/m2 body surface area administered on day 1 of each subsequent cycle for 6 cycles in total.
Croatian: Preporučena doza lijeka Truxima u kombinaciji s kemoterapijom za prethodno neliječene bolesnike i bolesnike koji nisu odgovorili na liječenje ili su u relapsu iznosi 375 mg/m2 tjelesne površine primijenjeno nultog dana prvog ciklusa liječenja, nakon čega slijedi 500 mg/m2 tjelesne površine primijenjeno prvog dana svakog sljedećeg ciklusa, tijekom ukupno 6 ciklusa.
English: Rituximab (n = 99)
Croatian: Rituksimab (n = 99)
English: Repeated treatment courses with
Croatian: U 60 ponovljenih liječenja u ispitivanju
English: How Truxima is given How it is given
Croatian: Kako se primjenjuje lijek Truxima Kako se Truxima primjenjuje
English: This should be followed by oral prednisone 1 mg/kg/day (not to exceed 80 mg/day, and tapered as rapidly as possible based on clinical need)
Croatian: Nakon toga treba tijekom i nakon 4-tjednog ciklusa uvodnog liječenja lijekom Truxima treba peroralno davati prednizon u dozi od 1 mg/kg na dan (ne više od 80 mg na dan i što brže postupno smanjivati dozu, ovisno o kliničkoj potrebi).
English: Truxima is indicated for the treatment of patients with CD20 positive diffuse large B cell non-Hodgkin's lymphoma in combination with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy.
Croatian: Truxima je u kombinaciji s CHOP kemoterapijom (ciklofosfamid, doksorubicin, vinkristin, prednizolon)
English: Patients in both arms received 1000 mg of pulse intravenous (IV) methylprednisolone (or another equivalent-dose glucocorticoid) per day for 1 to 3 days, followed by oral prednisone (1 mg/kg/day, not exceeding 80 mg/day).
Croatian: terapiju metilprednizolonom u dozi od 1000 mg na dan (ili drugi glukokortikoid u ekvivalentnoj dozi), a zatim peroralni prednizon (1 mg/kg na dan, ali ne više od 80 mg na dan).
English: b) If you are being treated for chronic lymphocytic leukaemia
Croatian: b) Bolesnici koji se liječe od kronične limfocitne leukemije
English: The recommended dose of Truxima used as a maintenance treatment for patients with previously untreated follicular lymphoma who have responded to induction treatment is: 375 mg/m2 body surface area once every 2 months (starting 2 months after the last dose of induction therapy) until disease progression or for a maximum period of two years (12 infusions in total).
Croatian: Preporučena doza lijeka Truxima u terapiji održavanja u bolesnika s prethodno neliječenim folikularnim limfomom koji su odgovorili na uvodno liječenje iznosi 375 mg/m2 površine tijela jedanput svaka 2 mjeseca (počevši 2 mjeseca nakon zadnje doze uvodne terapije) do progresije bolesti ili najdulje dvije godine (ukupno 12 infuzija).
English: This is because some people have a fall in their blood pressure while they are being given Truxima.
Croatian: 12 sati prije primjene lijeka Truxima zato što nekim bolesnicima može pasti krvni tlak tijekom primjene lijeka Truxima.
English: The recommended dose of Truxima used as a maintenance treatment for patients with relapsed/refractory follicular lymphoma who have responded to induction treatment is: 375 mg/m2 body surface area once every 3 months (starting 3 months after the last dose of induction therapy) until disease progression or for a maximum period of two years (8 infusions in total).
Croatian: Preporučena doza lijeka Truxima u terapiji održavanja u bolesnika s relapsirajućim/refraktornim folikularnim limfomom koji su odgovorili na uvodno liječenje iznosi 375 mg/m2 površine tijela jedanput svaka 3 mjeseca (počevši 3 mjeseca nakon zadnje doze uvodne terapije) do progresije bolesti ili najdulje dvije godine (ukupno 8 infuzija).
English: The recommended dosage of Truxima for the treatment of pemphigus vulgaris is 1000 mg administered as an IV infusion followed two weeks later by a second 1000 mg IV infusion in combination with a tapering course of glucocorticoids.
Croatian: Preporučena doza lijeka Truxima za liječenje običnog pemfigusa iznosi 1000 mg primijenjeno intravenskom infuzijom, a potom se nakon dva tjedna primjenjuje druga doza od 1000 mg intravenskom infuzijom u kombinaciji s glukokortikoidima čija se doza postupno smanjuje.
English: • swelling of the stomach.
Croatian: • glavobolja • bol u trbuhu
English: cell return, with counts >10 cells/μL by month 12, increasing to 87% of patients by month 18.
Croatian: mjeseca, što se povećalo na 87 % bolesnika do 18. mjeseca.
English: • mood disorders such as irritability and depression
Croatian: • infekcije poput herpesa i infekcija oka • poremećaji raspoloženja poput razdražljivosti i depresije
English: severe vision loss5
Croatian: konjunktivitis težak gubitak vida5
English: cell return, with counts > 10 cells/μL by month 12, increasing to 87% of patients by month 18.
Croatian: Većina je bolesnika (81 %) pokazala znakove povrata B stanica, uz vrijednosti od > 10 stanica/µl do 12. mjeseca, što se povećalo na 87 %
English: Initial treatment, in combination with chemotherapy In an open-label randomised trial, a total of 322 previously untreated patients with follicular lymphoma were randomised to receive either CVP chemotherapy (cyclophosphamide 750 mg/m2, vincristine 1.4 mg/m2 up to a maximum of 2 mg on day 1, and prednisolone 40 mg/m2/day on days 1-5) every 3 weeks for 8 cycles or rituximab 375 mg/m2 in combination with CVP (R-CVP).
Croatian: U otvorenom randomiziranom ispitivanju ukupno su 322 prethodno neliječena bolesnika s folikularnim limfomom slučajnim odabirom određena za primanje CVP kemoterapije (ciklofosfamid 750 mg/m2, vinkristin 1,4 mg/m2 do najviše 2 mg prvog dana liječenja, prednizolon 40 mg/m2/dan od prvog do petog dana liječenja) svaka 3 tjedna u 8 ciklusa liječenja, ili rituksimaba u dozi od 375 mg/m2 u kombinaciji s CVP kemoterapijom (R-CVP).
English: TTP - Time to progression or death PFS - Progression-Free Survival TTF - Time to Treatment Failure OS rates - survival rates at the time of the analyses
Croatian: Time to progression or death) PFS - preživljenje bez progresije bolesti (engl.
English: Truxima 500 mg concentrate for solution for infusion
Croatian: Truxima 500 mg koncentrat za otopinu za infuziju
English: sciatica, migraine, dizziness
Croatian: mučnina, osip, vrućica, svrbež,
English: Table 3 Adverse drug reactions occurring at 6-months in ≥ 5% of patients receiving rituximab for induction of remission of GPA and MPA, and at a higher frequency than the comparator group.
Croatian: Tablica 3 Nuspojave koje su u 6 mjeseci nastupile u ≥ 5 % bolesnika koji su primali lijek rituksimab za poticanje remisije GPA i MPA i koje su se javile s većom učestalošću nego u usporednoj skupini
English: Each course of treatment is made up of two separate infusions which are given 2 weeks apart.
Croatian: e) Bolesnici koji se liječe od običnog pemfigusa Svaki se ciklus liječenja sastoji od dvije zasebne infuzije koje se daju u razmaku od 2 tjedna.
English: Table 10b First-line treatment of chronic lymphocytic leukaemia Hazard ratios of progression-free survival according to Binet stage (ITT) - 48.1 months median observation time
Croatian: Omjeri hazarda za preživljenje bez progresije bolesti prema Binetovom stadiju (ITT populacija) - medijan vremena promatranja je 48,1 mjesec Preživljenje bez progresije bolesti (PFS)
English: granulomatosis with polyangiitis, microscopic polyangiitis or pemphigus vulgaris.
Croatian: granulomatozu s poliangiitisom, mikroskopski poliangiitis ili obični pemfigus.
English: Very common side effects (may affect more than 1 in 10 people): allergic reactions that are most likely to occur during an infusion, but can occur up to 24 hours after infusion long lasting depression loss of hair
Croatian: Vrlo rijetke nuspojave (mogu se javiti u do 1 na 10 000 osoba): skup simptoma koji se pojavljuju u roku od nekoliko tjedana od primitka infuzije lijeka
English: Truxima is indicated for the treatment of previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy.
Croatian: Truxima je u kombinaciji s kemoterapijom indicirana u liječenju bolesnika oboljelih od folikularnog limfoma stadija III-IV koji prethodno nisu liječeni.
English: The recommended dose of Truxima monotherapy used as induction treatment for adult patients with stage III-IV follicular lymphoma who are chemoresistant or are in their second or subsequent relapse after chemotherapy is: 375 mg/m2 body surface area, administered as an intravenous infusion once weekly for 4 weeks.
Croatian: • Relapsirajući/refraktorni folikularni limfom Preporučena doza lijeka Truxima u monoterapiji kod uvodnog liječenja odraslih bolesnika oboljelih od folikularnog limfoma stadija III-IV koji su rezistentni na kemoterapiju ili su u drugom odnosno sljedećem relapsu nakon kemoterapije iznosi 375 mg/m2 površine tijela, a primjenjuje se u obliku intravenske infuzije jedanput tjedno tijekom četiri tjedna.
English: Truxima 100 mg concentrate for solution for infusion
Croatian: Truxima 100 mg koncentrat za otopinu za infuziju
English: • a complex of symptoms occurring within a few weeks of an infusion of Truxima including allergic like reactions such as rash, itching, joint pain, swollen lymph glands and fever
Croatian: Truxima, a obuhvaćaju reakcije nalik alergijskima kao što su osip, svrbež, bol u zglobovima, otečeni limfni čvorovi i vrućica.
English: Package leaflet: Information for the patient Truxima 500 mg concentrate for solution for infusion rituximab This medicine is subject to additional monitoring.
Croatian: Uputa o lijeku: Informacije za bolesnika Truxima 500 mg koncentrat za otopinu za infuziju rituksimab
English: Duration of response* Disease free survival (DFS)** Time to new treatment
Croatian: Progression Free Survival) TTF - vrijeme do prestanka učinka liječenja (engl.
English: Also do not breast-feed for 12 months after your last treatment with Truxima.
Croatian: Ne smijete dojiti dijete tijekom liječenja lijekom Truxima i još 12 mjeseci nakon posljednje primjene lijeka jer se Truxima može izlučiti u majčino mlijeko.
English: Package leaflet: Information for the patient Truxima 100 mg concentrate for solution for infusion rituximab This medicine is subject to additional monitoring.
Croatian: Uputa o lijeku: Informacije za bolesnika Truxima 100 mg koncentrat za otopinu za infuziju rituksimab
English: Less frequently, some patients may experience pain at the infusion site, blisters, itching, sickness (nausea), tiredness, headache, breathing difficulties, blood pressure raised, wheezing, throat discomfort, tongue or throat swelling, itchy or runny nose, vomiting, flushing or palpitations, heart attack or low number of platelets.
Croatian: otežano disanje, povišen krvni tlak, piskanje pri disanju, nelagoda u grlu, natečenost jezika ili grla, svrbež ili curenje nosa, povraćanje, crvenilo praćeno osjećajem vrućine ili osjećaj lupanja srca, srčani udar ili malen broj krvnih pločica (trombocita).
English: during and after the 4 week induction course of Truxima treatment.
Croatian: Truxima ili nekoliko mjeseci nakon liječenja lijekom Truxima.
English: You might get infections more easily during your treatment with Truxima.
Croatian: Tijekom liječenja lijekom Truxima možda ćete biti podložniji infekcijama.
English: Muscle weakness Musculoskeletal pain Pain in extremities
Croatian: artralgija bol u leđima mišićna slabost bol u kostima i mišićima bol u udovima
English: R‐CHOP
Croatian: Liječenje R-CHOP
English: Truxima 500 mg concentrate for solution for infusion Rituximab
Croatian: Truxima 500 mg koncentrat za otopinu za infuziju rituksimab
English: PATIENT ALERT CARD TEXT FOR NON-ONCOLOGY INDICATIONS Truxima (Rituximab) Alert Card for patients with non-oncology diseases Why have I been given this card?
Croatian: Truxima (rituksimab) kartica s upozorenjima za bolesnike s neonkološkim bolestima
English: • If you are having Truxima with chemotherapy Truxima will be given to you on the same day as your chemotherapy.
Croatian: ako se liječite lijekom Truxima u kombinaciji s kemoterapijom Lijek Truxima primit ćete istoga dana kao i kemoterapiju, koja se obično daje do 8 puta u razmacima od 3 tjedna.
English: Log-rank p value
Croatian: log-rang pvrijednost
English: Truxima 100 mg concentrate for solution for infusion Rituximab
Croatian: Truxima 100 mg koncentrat za otopinu za infuziju rituksimab
English: d) If you are being treated for granulomatosis with polyangiitis or microscopic polyangiitis
Croatian: d) Bolesnici koji se liječe od granulomatoze s poliangiitisom ili mikroskopskog poliangiitisa
English: In the pivotal trial, 166 patients with relapsed or chemoresistant low-grade or follicular B cell NHL received 375 mg/m2 of rituximab as an intravenous infusion once weekly for four weeks.
Croatian: Početno liječenje, jedanput tjedno tijekom 4 tjedna U pivotalnom je ispitivanju 166 bolesnika s relapsirajućim ili kemorezistentnim, nisko malignim ili folikularnim B-staničnim ne-Hodgkinovim limfomom primilo rituksimab u dozi od 375 mg/m2 putem intravenske infuzije jedanput tjedno tijekom četiri tjedna.
English: Progression‐free survival (PFS)
Croatian: Preživljenje bez progresije (PFS)
English: Musculoskeletal and connective tissue disorders
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva grčevi mišića
English: System organ class
Croatian: American College of
English: The recommended dose of Truxima in combination with chemotherapy for induction treatment of previously untreated or relapsed/refractory patients with follicular lymphoma is: 375 mg/m2 body surface area per cycle, for up to 8 cycles.
Croatian: Preporučena doza lijeka Truxima u kombinaciji s kemoterapijom za uvodno liječenje bolesnika s prethodno neliječenim ili relapsirajućim/refraktornim folikularnim limfomom iznosi 375 mg/m2
English: • The need for close supervision during administration in an environment where full resuscitation facilities are immediately available
Croatian: Informacije za liječnike o lijeku Truxima moraju sadržavati sljedeće ključne elemente: • Neophodan je poman nadzor tijekom primjene u okruženju u kojem su izravno dostupni svi uređaji za oživljavanje.
English: Experience from granulomatosis with polyangiitis and microscopic polyangiitis Induction of remission
Croatian: Iskustva s primjenom kod granulomatoze s poliangitisom i mikroskopskog poliangitisa
English: In patients with granulomatosis with polyangiitis or microscopic polyangiitis, the number of peripheral blood B cells decreased to < 10 cells/μL after two weekly infusions of rituximab 375 mg/m2, and remained at that level in most patients up to the 6 month time point.
Croatian: U bolesnika s granulomatozom s poliangiitisom i mikroskopskim poliangiitisom broj perifernih B stanica smanjio se na < 10 stanica/µl nakon dvije tjedne infuzije rituksimaba u dozi od
English: In particular, tell your doctor:
Croatian: Karticu pokažite svakom liječniku,
English: Hazard ratio (95% CI)
Croatian: Razlika (CI 95 %)
English: Very Rare Not known disorders Cardiac disorders
Croatian: Ispitivanjima prethodno neliječenog i relapsirajućeg/refraktornog
English: Following induction of remission with Truxima, maintenance treatment should be initiated no sooner than 16 weeks after the last Truxima infusion.
Croatian: Nakon primjene lijeka Truxima za poticanje remisije, terapiju održavanja treba započeti najmanje 16